Acro Biomedical (ACBM) Profit After Tax Growth (5y) (2020 - 2026)
Analysis
Acro Biomedical (ACBM) Profit After Tax Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.49% |
| Sep 30, 2025 | -10.02% |
| Jun 30, 2025 | 24.56% |
| Mar 31, 2025 | -16.29% |
| Dec 31, 2024 | 32.45% |
| Sep 30, 2024 | 48.97% |
| Jun 30, 2024 | 45.98% |
| Mar 31, 2024 | 41.89% |
| Dec 31, 2023 | 24.63% |
| Sep 30, 2023 | -65.31% |
| Jun 30, 2023 | -96.74% |
| Mar 31, 2023 | -126.53% |
| Dec 31, 2022 | -119.58% |
| Sep 30, 2022 | -152.95% |
| Jun 30, 2022 | -220.13% |
| Mar 31, 2022 | -180.95% |
| Dec 31, 2021 | -249.27% |
| Sep 30, 2021 | -244.91% |
| Jun 30, 2021 | -115.43% |
| Mar 31, 2021 | -56.44% |